Perspective Therapeutics, Inc. — Director's Dealing 2014

Jul 2, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IsoRay, Inc. (ISR)
CIK: 0000728387
Period of Report: 2014-06-03

Reporting Person: Swindler Fredric (Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-06-03	Common Stock	M	25000	$0.26	Acquired	25000	Direct
2014-06-03	Common Stock	S	25000	$2.27	Disposed	0	Direct
2014-06-10	Common Stock	M	25000	$0.26	Acquired	25000	Direct
2014-06-10	Common Stock	S	25000	$2.5424	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-06-03	Stock Options	$0.26	M	25000	Disposed	2019-06-01	Common Stock (25000)	Direct
2014-06-10	Stock Options	$0.26	M	25000	Disposed	2019-06-01	Common Stock (25000)	Direct

Footnotes

F1: right to buy.

F2: represents a June 1, 2009 grant, all of which were exercisable as of June 1, 2012.